Roche K, Racowsky C, Harper J. Utilization of preimplantation genetic testing in the USA. J Assist Reprod Genet. 2021;38(5):1045–53.

Article  PubMed  PubMed Central  Google Scholar 

Hipp HS, et al. Trends and outcomes for preimplantation genetic testing in the United States, 2014–2018. JAMA. 2022;327(13):1288–90.

Article  PubMed  PubMed Central  Google Scholar 

Spinella F, et al. ESHRE PGT Consortium data collection XXI: PGT analyses in 2018. Hum Reprod Open. 2023;2023(2):hoad010. https://doi.org/10.1093/hropen/hoad010

Ljunger E, et al. Chromosomal anomalies in first-trimester miscarriages. Acta Obstet Gynecol Scand. 2005;84(11):1103–7.

Article  PubMed  Google Scholar 

Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet. 1985;70(1):11–7.

Article  CAS  PubMed  Google Scholar 

Franasiak JM, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656–663.e1.

Article  PubMed  Google Scholar 

Munné S, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019;112(6):1071–1079.e7.

Article  PubMed  Google Scholar 

Yan J, et al. Live Birth with or without preimplantation genetic testing for aneuploidy. N Engl J Med. 2021;385(22):2047–58.

Article  CAS  PubMed  Google Scholar 

The use of preimplantation genetic testing for aneuploidy(PGT-A): a committee opinion. Fertil Steril. 2018;109(3):429–436. https://doi.org/10.1016/j.fertnstert.2018.01.002

Lundin K, et al. Good practice recommendations on add-ons in reproductive medicine†. Hum Reprod. 2023;38(11):2062–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott RT Jr, et al. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100(3):624–30.

Article  PubMed  Google Scholar 

Cimadomo D, et al. The dawn of the future: 30 years from the first biopsy of a human embryo. The detailed history of an ongoing revolution. Hum Reprod Update. 2020;26(4):453–473.

Gauster M, et al. Early human trophoblast development: from morphology to function. Cell Mol Life Sci. 2022;79(6):345.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Afshar Y, et al. Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium. Am J Obstet Gynecol. 2024;230(4):443.e1–443.e18.

Article  PubMed  Google Scholar 

Liu X, et al. What we know about placenta accreta spectrum (PAS). Eur J Obstet Gynecol Reprod Biol. 2021;259:81–9.

Article  PubMed  Google Scholar 

Cahill AG, et al. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219(6):B2–b16.

Article  PubMed  Google Scholar 

Illsley NP, et al. Trophoblast invasion: lessons from abnormally invasive placenta (placenta accreta). Placenta. 2020;102:61–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Modest AM, et al. Placenta accreta spectrum: in vitro fertilization and non-in vitro fertilization and placenta accreta spectrum in a Massachusetts Cohort. Am J Perinatol. 2021;38(14):1533–9.

Article  PubMed  Google Scholar 

Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529–36.

Article  PubMed  Google Scholar 

Stroup DF, et al. Meta-analysis of observational studies in epidemiologya proposal for reporting. JAMA. 2000;283(15):2008–12.

Article  CAS  PubMed  Google Scholar 

Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45.

Article  PubMed  PubMed Central  Google Scholar 

Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–90.

Article  Google Scholar 

Swanson K, et al. Is preimplantation genetic testing associated with increased risk of abnormal placentation after frozen embryo transfer? Am J Perinatol. 2021;38(2):105–10.

Article  PubMed  Google Scholar 

Bay B, et al. Preimplantation genetic diagnosis: a national multicenter obstetric and neonatal follow-up study. Fertil Steril. 2016;106(6):1363–1369.e1.

Article  PubMed  Google Scholar 

Hasson J, et al. Obstetric and neonatal outcomes of pregnancies conceived after preimplantation genetic diagnosis: cohort study and meta-analysis. Reprod Biomed Online. 2017;35(2):208–18.

Article  PubMed  Google Scholar 

Zhang WY, et al. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019;112(2):283–290.e2.

Article  PubMed  PubMed Central  Google Scholar 

Makhijani R, et al. Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles. Hum Reprod. 2021;36(2):340–8.

Article  CAS  PubMed  Google Scholar 

Gulersen M, et al. Maternal and neonatal outcomes in pregnancies conceived after preimplantation genetic testing. Prenat Diagn. 2021;41(7):835–42.

Article  PubMed  Google Scholar 

Sites CK, et al. Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer. Am J Obstet Gynecol. 2021;225(3):285.e1–285.e7.

Article  CAS  PubMed  Google Scholar 

Feldman B, et al. Obstetric and perinatal outcomes in pregnancies conceived after preimplantation genetic testing for monogenetic diseases. Obstet Gynecol. 2020;136(4):782–91.

Article  CAS  PubMed  Google Scholar 

Salmanian B, Arian SE, Shamshirsaz AA. The role of in vitro fertilizationeembryo transfer in the development of placenta accreta spectrum. Am J Obstet Gynecol. 2021;225(4):462.

Article  PubMed  Google Scholar 

Huang J, et al. Trophectoderm grade is associated with the risk of placenta previa in frozen-thawed single blastocyst transfer cycles. Hum Reprod. 2023;38: i318.

Article  Google Scholar 

Kaser DJ, et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril. 2015;103(5):1176–84.e2.

Article  PubMed  Google Scholar 

Carusi DA, et al. A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology. F S Rep. 2023;4(3):279–85.

PubMed  PubMed Central  Google Scholar 

Saito K, et al. Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus. Hum Reprod. 2019;34(8):1567–75.

Article  PubMed  Google Scholar 

Sakai Y, et al. Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum. J Obstet Gynaecol Res. 2019;45(12):2394–9.

Article  CAS  PubMed  Google Scholar 

Busnelli A, et al. Obstetric and perinatal outcomes following programmed compared to natural frozen-Thawed embryo transfer cycles: a systematic review and meta-analysis. Hum Reprod. 2022;37(7):1619–41.

Article  CAS